Skip to main content

Shook David

In the past year, 2 open-market sale filings worth $31.3K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$31.3K
2 filings
Net
−$31.3K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Shook David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

LYEL Lyell Immunopharma, Inc.

Chief Medical Officer2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 10, 2026 (view filing)7:37 PM ETSep 10Same dayShook DavidChief Medical OfficerSSale−500$12.70−$6.35K−2.4%20.4K after
Jun 11, 2026 (view filing)Jun 101 dayShook DavidChief Medical OfficerSSale−1.98K$12.64−$25.0K−8.6%20.9K after

NKTX Nkarta, Inc.

See Remarks6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 17, 2025 (view filing)Jan 152 daysShook DavidSee RemarksSSale−8.64K$2.20−$19.0K−4.3%191.0K after
Jun 20, 2024 (view filing)Jun 182 daysShook DavidChief Medical OfficerSSale−456$5.60−$2.55K−0.4%116.5K after
Jan 18, 2024 (view filing)Jan 162 daysShook DavidChief Medical OfficerSSale−3.55K$8.74−$31.0K−3.0%115.0K after
Aug 23, 2023 (view filing)Aug 212 daysShook DavidChief Medical OfficerSSale−1.33K$1.83−$2.44K−2.2%60.5K after
Jun 22, 2023 (view filing)Jun 202 daysShook DavidChief Medical OfficerSSale−439$4.85−$2.13K−0.7%61.9K after
Jan 18, 2023 (view filing)Jan 171 dayShook DavidChief Medical OfficerSSale−175$5.49−$960.75−0.3%60.3K after